CCEL Logo

Cryo-Cell International, Inc. (CCEL) 

NASDAQ
Market Cap
$52.64M
Sector
Healthcare
Industry
Medical—Care Facilities
Rank in Sector
493 of 790
Rank in Industry
30 of 40

Largest Insider Buys in Sector

CCEL Stock Price History Chart

CCEL Stock Performance

About Cryo-Cell International, Inc.

Cryo-Cell International, Inc. engages in the cellular processing and cryogenic cellular storage with a focus on the collection and preservation of umbilical cord blood stem cells for family use. It provides cord tissue service that stores a section of the umbilical cord tissue, a source of mesenchymal stem cells that are used in regenerative medicine to treat a range of conditions, including heart, and kidney disease, ALS, wound healing, and auto-immune diseases. The company also manufactures and sells PrepaCyte CB processing system, a …

Insider Activity of Cryo-Cell International, Inc.

Over the last 12 months, insiders at Cryo-Cell International, Inc. have bought $0 and sold $0 worth of Cryo-Cell International, Inc. stock.

On average, over the past 5 years, insiders at Cryo-Cell International, Inc. have bought $683,027 and sold $668,903 worth of stock each year.

There was no buying activity among insiders over the last 12 months.

The last purchase of 534 shares for transaction amount of $2,617 was made by PORTNOY DAVID (Chairman, Co‑CEO) on 2022‑11‑18.

List of Insider Buy and Sell Transactions, Cryo-Cell International, Inc.

2022-11-18PurchaseChairman, Co-CEO
534
0.0063%
$4.90$2,617-3.47%
2022-11-17PurchaseChairman, Co-CEO
516
0.0061%
$4.90$2,528-3.47%
2022-11-15SaleChairman, Co-CEO
16,000
0.1842%
$4.80$76,860-3.65%
2022-11-15PurchaseChairman, Co-CEO
9,491
0.1092%
$4.80$45,557-3.65%
2022-11-14SaleChairman, Co-CEO
10,000
0.1152%
$4.80$48,000-3.25%
2022-11-14PurchaseChairman, Co-CEO
10,000
0.1152%
$4.80$48,000-3.25%
2022-11-11SaleChairman, Co-CEO
9,495
0.1126%
$4.79$45,471-0.31%
2022-11-11PurchaseChairman, Co-CEO
6,000
0.0711%
$4.79$28,710-0.31%
2022-11-10SaleChairman, Co-CEO
5,505
0.0645%
$4.91$27,015-3.84%
2022-11-10PurchaseChairman, Co-CEO
3,850
0.045%
$4.90$18,865-3.84%
2022-11-08SaleChairman, Co-CEO
15,000
0.1866%
$5.02$75,350-0.21%
2022-11-08PurchaseChairman, Co-CEO
20,000
0.2424%
$4.89$97,900-0.21%
2021-09-01Saledirector
3,699
0.0416%
$11.70$43,278-33.46%
2021-08-31Saledirector
2,330
0.0276%
$11.61$27,057-29.18%
2021-08-30Saledirector
10,000
0.1355%
$11.48$114,800-27.19%
2021-07-23PurchaseChairman, Co-CEO
158
0.0021%
$9.45$1,493-2.75%
2021-07-19PurchaseChairman, Co-CEO
100
0.0013%
$9.23$924+0.00%
2021-05-27PurchaseChairman, Co-CEO
946
0.0134%
$8.65$8,183+9.83%
2021-05-21PurchaseChairman, Co-CEO
1,000
0.0142%
$8.46$8,460+12.29%
2021-05-13PurchaseChairman, Co-CEO
2,000
0.0284%
$8.55$17,100+11.11%

Insider Historical Profitability

22.07%
Choi Ki Yong
2144929
26.6061%
$6.5390+12.89%
SHEEHY BRIAN L.director
496503
6.1587%
$6.5360
Portnoy Mark L.Co-Chief Executive Officer
487514
6.0472%
$6.53216
PORTNOY DAVIDChairman, Co-CEO
230621
2.8607%
$6.5314818+8.21%
Wheeler Jonathan H.director
76600
0.9502%
$6.5340

Institutional Investor Ownership

Top Shareholders
Top Buyers
Top Sellers
New Shareholders
Sold-Out Shareholders
Hamilton Lane$3.06M5.08409,7340%+$02.09
SFI Advisors$1.23M2.05165,3000%+$01.41
Massmutual Trust Co Fsb Adv$828,321.001.38111,035-2.78%-$23,707.880.03
The Vanguard Group$693,325.001.1592,939+1.98%+$13,428.00<0.0001
Northern Trust$174,400.000.2923,378-11.11%-$21,798.13<0.0001
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.